Fenofibrate Increases Circulating Hematopoietic Stem Cells in People with Diabetic Retinopathy: A Randomized, Placebo-Controlled Trial

The authors investigated whether fenofibrate increased circulating hematopoietic stem/progenitor cells (HSPCs). When compared with placebo, fenofibrate significantly increased levels of HSPCs expressing CD34 and/or CD133.